CLINICAL_TRIALS
trial_result
· 2022-03-02
Clinical Trial Update: A Study Evaluating ClariVein With a Sclerosing Agent for the Treatment of Venous Insufficiency [Phase 2]
Summary
A Phase 2 trial evaluating ClariVein with a sclerosing agent for venous insufficiency has been terminated; results posted in 2022.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Vascular Insights, LLC | Conditions: Venous Insufficiency | Phase 2 | Status: TERMINATED | Results posted: 2022-03-02